These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 576372)

  • 61. [Dosage of prolactin in normal and pathological subjects (author's transl)].
    Franchimont P; Dourcy C; Legros JJ; Reuter A; Vrindts-Gevaert Y; van Cauwenberge JR; Remacle P; Gaspard U; Colin C
    Ann Endocrinol (Paris); 1976; 37(3):127-56. PubMed ID: 828474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Netter A; Netter AL; Gorins A
    Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
    [No Abstract]   [Full Text] [Related]  

  • 63. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors.
    Kletzky OA; Davajan V; Mishell DR; Nicoloff JT; Mims R; March CM; Nakamura RM
    J Clin Endocrinol Metab; 1977 Oct; 45(4):631-40. PubMed ID: 410820
    [No Abstract]   [Full Text] [Related]  

  • 64. Pregnancy following metergoline treatment in a patient with hyperprolactinaemia.
    Crosignani PG; Reschini E; Peracchi M; D'Alberton A; Lombroso GC
    Br J Obstet Gynaecol; 1977 May; 84(5):386-8. PubMed ID: 889732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 66. Amenorrhea following oral contraception.
    Smiljanić N; Ciglar S; Bistricki J
    Acta Obstet Gynecol Scand; 1980; 59(3):261-4. PubMed ID: 6775490
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Yellow body function in bromocryptine induced early pregnancy in patients with hyperprolactinemia (author's transl)].
    Smiljanić N; Ciglar S; Podobnik M
    Jugosl Ginekol Opstet; 1981; 21(3-4):65-9. PubMed ID: 6803072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
    Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
    [No Abstract]   [Full Text] [Related]  

  • 69. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea].
    Campagnoli C; Belforte L; Bruno M; Fessia L; Pinna N; Massara F
    Minerva Ginecol; 1980 May; 32(5):400-4. PubMed ID: 7393487
    [No Abstract]   [Full Text] [Related]  

  • 72. Ovulatory response to clomiphene citrate during bromocriptine-failed ovulation in amenorrhea-galactorrhea and hyperprolactinemia.
    Turksoy RN; Biller BJ; Farber M; Cetrulo C; Mitchell GW
    Fertil Steril; 1982 Mar; 37(3):441-4. PubMed ID: 6800855
    [No Abstract]   [Full Text] [Related]  

  • 73. Pituitary secretory reserve in patients with amenorrhea associated with galactorrhea.
    Zarate A; Canales ES; Soria J; Garrido J; Jacobs LS; Schally AV
    Ann Endocrinol (Paris); 1974; 35(5):535-45. PubMed ID: 4142845
    [No Abstract]   [Full Text] [Related]  

  • 74. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of galactorrhea-amenorrhea.
    De Leon FD
    Am Fam Physician; 1985 Dec; 32(6):121-4. PubMed ID: 4072865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of hyperprolactinemia-anovulation syndrome.
    Floersheim-Shachar Y; Keller PJ
    Fertil Steril; 1977 Nov; 28(11):1158-63. PubMed ID: 562780
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Amenorrhea-galactorrhea, hyperprolactinemia, and suprasellar pituitary enlargement as presenting features of primary hypothyroidism.
    Groff TR; Shulkin BL; Utiger RD; Talbert LM
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):86S-89S. PubMed ID: 6700889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of lergotrile on galactorrhea and gonadotropin secretion.
    Cleary RE; Crabtree R; Lemberger L
    J Clin Endocrinol Metab; 1975 May; 40(5):830-3. PubMed ID: 165221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Pregnancy with thyroid replacement and additional bromocriptine therapy in a patient of amenorrhea-galactorrhea syndrome due to primary hypothyroidism (author's transl)].
    Matsuura K; Mizumoto J; Maeyama M
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):305-8. PubMed ID: 7234339
    [No Abstract]   [Full Text] [Related]  

  • 80. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.